{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:31:21Z","timestamp":1792794681581,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2017,9,19]],"date-time":"2017-09-19T00:00:00Z","timestamp":1505779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2017,9,19]],"date-time":"2017-09-19T00:00:00Z","timestamp":1505779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["PP00P3_133661"],"award-info":[{"award-number":["PP00P3_133661"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["PP00P3_157527"],"award-info":[{"award-number":["PP00P3_157527"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"name":"FORCE, a Foundation for Children Cancer Research"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"published-print":{"date-parts":[[2017,11,1]]},"DOI":"10.15252\/emmm.201707814","type":"journal-article","created":{"date-parts":[[2017,9,18]],"date-time":"2017-09-18T20:20:20Z","timestamp":1505766020000},"page":"1589-1604","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Mutant CTNNB1 and histological heterogeneity define metabolic subtypes of hepatoblastoma"],"prefix":"10.1038","volume":"9","author":[{"given":"Stefania","family":"Crippa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre\u2010Benoit","family":"Ancey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Vazquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Angelino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne\u2010Laure","family":"Rougemont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Guettier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Zoete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Delorenzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Michielin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0899-2230","authenticated-orcid":false,"given":"Etienne","family":"Meylan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,19]]},"reference":[{"key":"BFEMMM201707814_CR1","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1093\/emboj\/16.13.3797","volume":"16","author":"H Aberle","year":"1997","unstructured":"Aberle H, Bauer A, Stappert J, Kispert A, Kemler R (1997) beta\u2010catenin is a target for the ubiquitin\u2010proteasome pathway. EMBO J 16: 3797\u20133804","journal-title":"EMBO J"},{"key":"BFEMMM201707814_CR2","doi-asserted-by":"crossref","first-page":"5735","DOI":"10.1093\/nar\/gkq363","volume":"38","author":"D Bottomly","year":"2010","unstructured":"Bottomly D, Kyler SL, McWeeney SK, Yochum GS (2010) Identification of {beta}\u2010catenin binding regions in colon cancer cells using ChIP\u2010Seq. Nucleic Acids Res 38: 5735\u20135745","journal-title":"Nucleic Acids Res"},{"key":"BFEMMM201707814_CR3","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1101\/gad.317604","volume":"18","author":"FH Brembeck","year":"2004","unstructured":"Brembeck FH, Schwarz\u2010Romond T, Bakkers J, Wilhelm S, Hammerschmidt M, Birchmeier W (2004) Essential role of BCL9\u20102 in the switch between beta\u2010catenin's adhesive and transcriptional functions. Genes Dev 18: 2225\u20132230","journal-title":"Genes Dev"},{"key":"BFEMMM201707814_CR4","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.ccr.2008.11.002","volume":"14","author":"S Cairo","year":"2008","unstructured":"Cairo S, Armengol C, De Reynies A, Wei Y, Thomas E, Renard CA, Goga A, Balakrishnan A, Semeraro M, Gresh L et\u00a0al (2008) Hepatic stem\u2010like phenotype and interplay of Wnt\/beta\u2010catenin and Myc signaling in aggressive childhood liver cancer. Cancer Cell 14: 471\u2013484","journal-title":"Cancer Cell"},{"key":"BFEMMM201707814_CR5","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1002\/pbc.22187","volume":"53","author":"TT Chen","year":"2009","unstructured":"Chen TT, Rakheja D, Hung JY, Hornsby PJ, Tabaczewski P, Malogolowkin M, Feusner J, Miskevich F, Schultz R, Tomlinson GE (2009) Establishment and characterization of a cancer cell line derived from an aggressive childhood liver tumor. Pediatr Blood Cancer 53: 1040\u20131047","journal-title":"Pediatr Blood Cancer"},{"key":"BFEMMM201707814_CR6","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1101\/gad.229062.113","volume":"27","author":"SH Choi","year":"2013","unstructured":"Choi SH, Estaras C, Moresco JJ, Yates JR III, Jones KA (2013) alpha\u2010Catenin interacts with APC to regulate beta\u2010catenin proteolysis and transcriptional repression of Wnt target genes. Genes Dev 27: 2473\u20132488","journal-title":"Genes Dev"},{"key":"BFEMMM201707814_CR7","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.cell.2012.05.012","volume":"149","author":"H Clevers","year":"2012","unstructured":"Clevers H, Nusse R (2012) Wnt\/beta\u2010catenin signaling and disease. Cell 149: 1192\u20131205","journal-title":"Cell"},{"key":"BFEMMM201707814_CR8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/MOP.0000000000000046","volume":"26","author":"P Czauderna","year":"2014","unstructured":"Czauderna P, Lopez\u2010Terrada D, Hiyama E, Haberle B, Malogolowkin MH, Meyers RL (2014) Hepatoblastoma state of the art: pathology, genetics, risk stratification, and chemotherapy. Curr Opin Pediatr 26: 19\u201328","journal-title":"Curr Opin Pediatr"},{"key":"BFEMMM201707814_CR9","doi-asserted-by":"crossref","first-page":"5260","DOI":"10.1073\/pnas.1308663111","volume":"111","author":"RL Daugherty","year":"2014","unstructured":"Daugherty RL, Serebryannyy L, Yemelyanov A, Flozak AS, Yu HJ, Kosak ST, deLanerolle P, Gottardi CJ (2014) alpha\u2010Catenin is an inhibitor of transcription. Proc Natl Acad Sci USA 111: 5260\u20135265","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMMM201707814_CR10","doi-asserted-by":"crossref","first-page":"6619","DOI":"10.1158\/0008-5472.CAN-10-0148","volume":"70","author":"J Deka","year":"2010","unstructured":"Deka J, Wiedemann N, Anderle P, Murphy\u2010Seiler F, Bultinck J, Eyckerman S, Stehle JC, Andre S, Vilain N, Zilian O et\u00a0al (2010) Bcl9\/Bcl9l are critical for Wnt\u2010mediated regulation of stem cell traits in colon epithelium and adenocarcinomas. Cancer Res 70: 6619\u20136628","journal-title":"Cancer Res"},{"key":"BFEMMM201707814_CR11","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nature13306","volume":"510","author":"D Deng","year":"2014","unstructured":"Deng D, Xu C, Sun P, Wu J, Yan C, Hu M, Yan N (2014) Crystal structure of the human glucose transporter GLUT1. Nature 510: 121\u2013125","journal-title":"Nature"},{"key":"BFEMMM201707814_CR12","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nature14655","volume":"526","author":"D Deng","year":"2015","unstructured":"Deng D, Sun P, Yan C, Ke M, Jiang X, Xiong L, Ren W, Hirata K, Yamamoto M, Fan S et\u00a0al (2015) Molecular basis of ligand recognition and transport by glucose transporters. Nature 526: 391\u2013396","journal-title":"Nature"},{"key":"BFEMMM201707814_CR13","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.jhep.2014.08.009","volume":"61","author":"M Eichenmuller","year":"2014","unstructured":"Eichenmuller M, Trippel F, Kreuder M, Beck A, Schwarzmayr T, Haberle B, Cairo S, Leuschner I, von Schweinitz D, Strom TM et\u00a0al (2014) The genomic landscape of hepatoblastoma and their progenies with HCC\u2010like features. J Hepatol 61: 1312\u20131320","journal-title":"J Hepatol"},{"key":"BFEMMM201707814_CR14","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1002\/hep.27929","volume":"62","author":"W Guo","year":"2015","unstructured":"Guo W, Qiu Z, Wang Z, Wang Q, Tan N, Chen T, Chen Z, Huang S, Gu J, Li J et\u00a0al (2015) MiR\u2010199a\u20105p is negatively associated with malignancies and regulates glycolysis and lactate production by targeting hexokinase 2 in liver cancer. Hepatology 62: 1132\u20131144","journal-title":"Hepatology"},{"key":"BFEMMM201707814_CR15","first-page":"4097","volume":"72","author":"TK Ha","year":"2012","unstructured":"Ha TK, Her NG, Lee MG, Ryu BK, Lee JH, Han J, Jeong SI, Kang MJ, Kim NH, Kim HJ et\u00a0al (2012) Caveolin\u20101 increases aerobic glycolysis in colorectal cancers by stimulating HMGA1\u2010mediated GLUT3 transcription. Cancer Res 72: 4097\u20134109","journal-title":"Cancer Res"},{"key":"BFEMMM201707814_CR16","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.humpath.2005.12.015","volume":"37","author":"J Halasz","year":"2006","unstructured":"Halasz J, Holczbauer A, Paska C, Kovacs M, Benyo G, Verebely T, Schaff Z, Kiss A (2006) Claudin\u20101 and claudin\u20102 differentiate fetal and embryonal\u00a0components in human hepatoblastoma. Hum Pathol 37: 555\u2013561","journal-title":"Hum Pathol"},{"key":"BFEMMM201707814_CR17","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/35093131","volume":"413","author":"S Herzig","year":"2001","unstructured":"Herzig S, Long F, Jhala US, Hedrick S, Quinn R, Bauer A, Rudolph D, Schutz G, Yoon C, Puigserver P et\u00a0al (2001) CREB regulates hepatic gluconeogenesis through the coactivator PGC\u20101. Nature 413: 179\u2013183","journal-title":"Nature"},{"key":"BFEMMM201707814_CR18","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/ncb1724","volume":"10","author":"K Kawauchi","year":"2008","unstructured":"Kawauchi K, Araki K, Tobiume K, Tanaka N (2008) p53 regulates glucose metabolism through an IKK\u2010NF\u2010kappaB pathway and inhibits cell transformation. Nat Cell Biol 10: 611\u2013618","journal-title":"Nat Cell Biol"},{"key":"BFEMMM201707814_CR19","first-page":"269","volume":"59","author":"A Koch","year":"1999","unstructured":"Koch A, Denkhaus D, Albrecht S, Leuschner I, von Schweinitz D, Pietsch T (1999) Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the beta\u2010catenin gene. Cancer Res 59: 269\u2013273","journal-title":"Cancer Res"},{"key":"BFEMMM201707814_CR20","doi-asserted-by":"crossref","first-page":"10498","DOI":"10.1038\/ncomms10498","volume":"7","author":"W Lehmann","year":"2016","unstructured":"Lehmann W, Mossmann D, Kleemann J, Mock K, Meisinger C, Brummer T, Herr R, Brabletz S, Stemmler MP, Brabletz T (2016) ZEB1 turns into a transcriptional activator by interacting with YAP1 in aggressive cancer types. Nat Commun 7: 10498","journal-title":"Nat Commun"},{"key":"BFEMMM201707814_CR21","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.humpath.2008.07.022","volume":"40","author":"D Lopez\u2010Terrada","year":"2009","unstructured":"Lopez\u2010Terrada D, Gunaratne PH, Adesina AM, Pulliam J, Hoang DM, Nguyen Y, Mistretta TA, Margolin J, Finegold MJ (2009) Histologic subtypes of hepatoblastoma are characterized by differential canonical Wnt and Notch pathway activation in DLK+ precursors. Hum Pathol 40: 783\u2013794","journal-title":"Hum Pathol"},{"key":"BFEMMM201707814_CR22","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/modpathol.2013.80","volume":"27","author":"D Lopez\u2010Terrada","year":"2014","unstructured":"Lopez\u2010Terrada D, Alaggio R, de Davila MT, Czauderna P, Hiyama E, Katzenstein H, Leuschner I, Malogolowkin M, Meyers R, Ranganathan S et\u00a0al (2014) Towards an international pediatric liver tumor consensus classification: proceedings of the Los Angeles COG liver tumors symposium. Mod Pathol 27: 472\u2013491","journal-title":"Mod Pathol"},{"key":"BFEMMM201707814_CR23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/2049-3002-2-11","volume":"2","author":"M Masin","year":"2014","unstructured":"Masin M, Vazquez J, Rossi S, Groeneveld S, Samson N, Schwalie PC, Deplancke B, Frawley LE, Gouttenoire J, Moradpour D et\u00a0al (2014) GLUT3 is induced during epithelial\u2010mesenchymal transition and promotes tumor cell proliferation in non\u2010small cell lung cancer. Cancer Metab 2: 11","journal-title":"Cancer Metab"},{"key":"BFEMMM201707814_CR24","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nrm.2015.3","volume":"17","author":"PD McCrea","year":"2016","unstructured":"McCrea PD, Gottardi CJ (2016) Beyond beta\u2010catenin: prospects for a larger catenin network in the nucleus. Nat Rev Mol Cell Biol 17: 55\u201364","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFEMMM201707814_CR25","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.1158\/0008-5472.CAN-13-3275","volume":"74","author":"S Mokkapati","year":"2014","unstructured":"Mokkapati S, Niopek K, Huang L, Cunniff KJ, Ruteshouser EC, deCaestecker M, Finegold MJ, Huff V (2014) beta\u2010catenin activation in a novel liver progenitor cell type is sufficient to cause hepatocellular carcinoma and hepatoblastoma. Cancer Res 74: 4515\u20134525","journal-title":"Cancer Res"},{"key":"BFEMMM201707814_CR26","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1126\/science.1094291","volume":"303","author":"WJ Nelson","year":"2004","unstructured":"Nelson WJ, Nusse R (2004) Convergence of Wnt, beta\u2010catenin, and cadherin pathways. Science 303: 1483\u20131487","journal-title":"Science"},{"key":"BFEMMM201707814_CR27","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ccr.2014.06.018","volume":"26","author":"LH Nguyen","year":"2014","unstructured":"Nguyen LH, Robinton DA, Seligson MT, Wu L, Li L, Rakheja D, Comerford SA, Ramezani S, Sun X, Parikh MS et\u00a0al (2014) Lin28b is sufficient to drive liver cancer and necessary for its maintenance in murine models. Cancer Cell 26: 248\u2013261","journal-title":"Cancer Cell"},{"key":"BFEMMM201707814_CR28","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nature14909","volume":"526","author":"N Nomura","year":"2015","unstructured":"Nomura N, Verdon G, Kang HJ, Shimamura T, Nomura Y, Sonoda Y, Hussien SA, Qureshi AA, Coincon M, Sato Y et\u00a0al (2015) Structure and mechanism of the mammalian fructose transporter GLUT5. Nature 526: 397\u2013401","journal-title":"Nature"},{"key":"BFEMMM201707814_CR29","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.15252\/embj.201488598","volume":"33","author":"KT Pate","year":"2014","unstructured":"Pate KT, Stringari C, Sprowl\u2010Tanio S, Wang K, TeSlaa T, Hoverter NP, McQuade MM, Garner C, Digman MA, Teitell MA et\u00a0al (2014) Wnt signaling directs a metabolic program of glycolysis and angiogenesis in colon cancer. EMBO J 33: 1454\u20131473","journal-title":"EMBO J"},{"key":"BFEMMM201707814_CR30","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ccr.2013.06.014","volume":"24","author":"KC Patra","year":"2013","unstructured":"Patra KC, Wang Q, Bhaskar PT, Miller L, Wang Z, Wheaton W, Chandel N, Laakso M, Muller WJ, Allen EL et\u00a0al (2013) Hexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancer. Cancer Cell 24: 213\u2013228","journal-title":"Cancer Cell"},{"key":"BFEMMM201707814_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10863-012-9425-4","volume":"44","author":"PL Pedersen","year":"2012","unstructured":"Pedersen PL (2012) 3\u2010Bromopyruvate (3BP) a fast acting, promising, powerful, specific, and effective \u201csmall molecule\u201d anti\u2010cancer agent taken from labside to bedside: introduction to a special issue. J Bioenerg Biomembr 44: 1\u20136","journal-title":"J Bioenerg Biomembr"},{"key":"BFEMMM201707814_CR32","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1101\/gr.147678.112","volume":"23","author":"HM Rowe","year":"2013","unstructured":"Rowe HM, Kapopoulou A, Corsinotti A, Fasching L, Macfarlan TS, Tarabay Y, Viville S, Jakobsson J, Pfaff SL, Trono D (2013) TRIM28 repression of retrotransposon\u2010based enhancers is necessary to preserve transcriptional dynamics in embryonic stem cells. Genome Res 23: 452\u2013461","journal-title":"Genome Res"},{"key":"BFEMMM201707814_CR33","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.molcel.2006.09.001","volume":"24","author":"J Sampietro","year":"2006","unstructured":"Sampietro J, Dahlberg CL, Cho US, Hinds TR, Kimelman D, Xu W (2006) Crystal structure of a beta\u2010catenin\/BCL9\/Tcf4 complex. Mol Cell 24: 293\u2013300","journal-title":"Mol Cell"},{"key":"BFEMMM201707814_CR34","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/ijc.11082","volume":"105","author":"S Scheil","year":"2003","unstructured":"Scheil S, Hagen S, Bruderlein S, Leuschner I, Behnisch W, Moller P (2003) Two novel in\u00a0vitro human hepatoblastoma models, HepU1 and HepU2, are highly characteristic of fetal\u2010embryonal differentiation in hepatoblastoma. Int J Cancer 105: 347\u2013352","journal-title":"Int J Cancer"},{"key":"BFEMMM201707814_CR35","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nrc1633","volume":"5","author":"PJ Scotting","year":"2005","unstructured":"Scotting PJ, Walker DA, Perilongo G (2005) Childhood solid tumours: a developmental disorder. Nat Rev Cancer 5: 481\u2013488","journal-title":"Nat Rev Cancer"},{"key":"BFEMMM201707814_CR36","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/nature03043","volume":"431","author":"CM Shachaf","year":"2004","unstructured":"Shachaf CM, Kopelman AM, Arvanitis C, Karlsson A, Beer S, Mandl S, Bachmann MH, Borowsky AD, Ruebner B, Cardiff RD et\u00a0al (2004) MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer. Nature 431: 1112\u20131117","journal-title":"Nature"},{"key":"BFEMMM201707814_CR37","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s10863-012-9419-2","volume":"44","author":"MC Shoshan","year":"2012","unstructured":"Shoshan MC (2012) 3\u2010Bromopyruvate: targets and outcomes. J Bioenerg Biomembr 44: 7\u201315","journal-title":"J Bioenerg Biomembr"},{"key":"BFEMMM201707814_CR38","doi-asserted-by":"crossref","first-page":"7997","DOI":"10.1093\/nar\/gku430","volume":"42","author":"SM Tan","year":"2014","unstructured":"Tan SM, Altschuler G, Zhao TY, Ang HS, Yang H, Lim B, Vardy L, Hide W, Thomson AM, Lareu RR (2014) Divergent LIN28\u2010mRNA associations result in translational suppression upon the initiation of differentiation. Nucleic Acids Res 42: 7997\u20138007","journal-title":"Nucleic Acids Res"},{"key":"BFEMMM201707814_CR39","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1053\/j.gastro.2014.05.004","volume":"147","author":"J Tao","year":"2014","unstructured":"Tao J, Calvisi DF, Ranganathan S, Cigliano A, Zhou L, Singh S, Jiang L, Fan B, Terracciano L, Armeanu\u2010Ebinger S et\u00a0al (2014) Activation of beta\u2010catenin and Yap1 in human hepatoblastoma and induction of hepatocarcinogenesis in mice. Gastroenterology 147: 690\u2013701","journal-title":"Gastroenterology"},{"key":"BFEMMM201707814_CR40","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1158\/1541-7786.MCR-10-0011","volume":"8","author":"M Watanabe","year":"2010","unstructured":"Watanabe M, Naraba H, Sakyo T, Kitagawa T (2010) DNA damage\u2010induced modulation of GLUT3 expression is mediated through p53\u2010independent extracellular signal\u2010regulated kinase signaling in HeLa cells. Mol Cancer Res 8: 1547\u20131557","journal-title":"Mol Cancer Res"},{"key":"BFEMMM201707814_CR41","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/35093050","volume":"413","author":"JC Yoon","year":"2001","unstructured":"Yoon JC, Puigserver P, Chen G, Donovan J, Wu Z, Rhee J, Adelmant G, Stafford J, Kahn CR, Granner DK et\u00a0al (2001) Control of hepatic gluconeogenesis through the transcriptional coactivator PGC\u20101. Nature 413: 131\u2013138","journal-title":"Nature"},{"key":"BFEMMM201707814_CR42","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.cmet.2011.12.015","volume":"15","author":"MO Yuneva","year":"2012","unstructured":"Yuneva MO, Fan TW, Allen TD, Higashi RM, Ferraris DV, Tsukamoto T, Mates JM, Alonso FJ, Wang C, Seo Y et\u00a0al (2012) The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type. Cell Metab 15: 157\u2013170","journal-title":"Cell Metab"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.15252\/emmm.201707814.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.15252\/emmm.201707814","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.15252\/emmm.201707814\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.embopress.org\/doi\/pdf\/10.15252\/emmm.201707814","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.15252\/emmm.201707814.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T06:22:00Z","timestamp":1779085320000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.15252\/emmm.201707814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,19]]},"references-count":42,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11,1]]}},"alternative-id":["BFEMMM201707814"],"URL":"https:\/\/doi.org\/10.15252\/emmm.201707814","relation":{},"ISSN":["1757-4676","1757-4684"],"issn-type":[{"value":"1757-4676","type":"print"},{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,19]]},"assertion":[{"value":"17 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}